Testing effectiveness (Phase 2)Study completedNCT05018416
What this trial is testing
Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)
Who this might be right for
Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus
Prokidney 53